Search Results

There are 4596 results for: content related to: A Compendium of Antihypertensive Therapy

  1. You have free access to this content
    Aliskiren Alone or in Combination With Hydrochlorothiazide in Hispanic/Latino Patients With Systolic Blood Pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] Substudy)

    The Journal of Clinical Hypertension

    Volume 14, Issue 8, August 2012, Pages: 514–521, Henry R. Black, Fernando Aguirre P., Melanie Wright, Thomas Alessi and Fabio Baschiera

    Version of Record online : 7 JUN 2012, DOI: 10.1111/j.1751-7176.2012.00672.x

  2. Blood pressure lowering efficacy of renin inhibitors for primary hypertension

    Intervention Review

    The Cochrane Library

    Vijaya M Musini, Kendra AK Lawrence, Patricia M Fortin, Ken Bassett and James M Wright

    Published Online : 5 APR 2017, DOI: 10.1002/14651858.CD007066.pub3

  3. You have free access to this content
    Effects of Aliskiren-Based Therapy on Ambulatory Blood Pressure Profile, Central Hemodynamics, and Arterial Stiffness in Nondiabetic Mild to Moderate Hypertensive Patients

    The Journal of Clinical Hypertension

    Volume 14, Issue 8, August 2012, Pages: 522–529, Tomohiko Kanaoka, Kouichi Tamura, Masato Ohsawa, Hiromichi Wakui, Akinobu Maeda, Toru Dejima, Kengo Azushima, Sona Haku, Hiroshi Mitsuhashi, Mai Yanagi, Jin Oshikawa, Kazushi Uneda, Kazutaka Aoki, Tetsuya Fujikawa, Yoshiyuki Toya, Kazuaki Uchino and Satoshi Umemura

    Version of Record online : 3 MAY 2012, DOI: 10.1111/j.1751-7176.2012.00640.x

  4. Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P-Glycoprotein in the Disposition of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1323–1338, Dr Sujata Vaidyanathan, Dr Gian Camenisch, Dr Helmut Schuetz, Ms Christine Reynolds, Dr Ching-Ming Yeh, Dr Marie-Noelle Bizot, Dr Hans Armin Dieterich, Dr Dan Howard and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008323258

  5. You have free access to this content
    Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 4, April 2012, Pages: 470–481, Azhar Rashikh, Shibli Jameel Ahmad, Krishna Kolappa Pillai and Abul Kalam Najmi

    Version of Record online : 7 DEC 2011, DOI: 10.1111/j.2042-7158.2011.01414.x

  6. You have free access to this content
    Direct Renin Inhibition— Commonly Asked Questions

    The Journal of Clinical Hypertension

    Volume 10, Issue 11, November 2008, Pages: 871–875, Domenic A. Sica

    Version of Record online : 4 NOV 2008, DOI: 10.1111/j.1751-7176.2008.00039.x

  7. Aliskiren: An Oral Direct Renin Inhibitor for the Treatment of Hypertension

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 2, February 2009, Pages: 193–212, Cynthia A. Sanoski

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.2.193

  8. Aliskiren increases bradykinin and tissue kallikrein mRNA levels in the heart

    Clinical and Experimental Pharmacology and Physiology

    Volume 38, Issue 9, September 2011, Pages: 623–631, Duncan J Campbell, Yuan Zhang, Darren J Kelly, Richard E Gilbert, Davis J McCarthy, Wei Shi and Gordon K Smyth

    Version of Record online : 26 AUG 2011, DOI: 10.1111/j.1440-1681.2011.05572.x

  9. You have free access to this content
    Comparative Efficacy of Aliskiren/Valsartan vs Valsartan in Nocturnal Dipper and Nondipper Hypertensive Patients: A Pooled Analysis

    The Journal of Clinical Hypertension

    Volume 14, Issue 5, May 2012, Pages: 299–306, Thomas D. Giles, 1 Thomas Alessi, 2 Das Purkayastha and 2 Dion Zappe 2

    Version of Record online : 16 MAR 2012, DOI: 10.1111/j.1751-7176.2012.00608.x

  10. You have free access to this content
    Aliskiren in the Treatment of Hypertension and Organ Damage

    Cardiovascular Therapeutics

    Volume 29, Issue 1, February 2011, Pages: 77–87, Graziano Riccioni

    Version of Record online : 25 NOV 2010, DOI: 10.1111/j.1755-5922.2010.00230.x

  11. You have free access to this content
    Utilisation and Tolerability of Aliskiren in the Primary Care Setting in England

    The Journal of Clinical Hypertension

    Volume 18, Issue 12, December 2016, Pages: 1237–1243, Abigail L. Coughtrie, Claire Doe, Deborah Layton and Saad A. W. Shakir

    Version of Record online : 3 JUN 2016, DOI: 10.1111/jch.12852

  12. You have free access to this content
    Aliskiren Alone or in Combination With Hydrochlorothiazide in Patients With the Lower Ranges of Stage 2 Hypertension: The ACQUIRE Randomized Double-Blind Study

    The Journal of Clinical Hypertension

    Volume 12, Issue 12, December 2010, Pages: 917–926, Henry R. Black, Andreas Kribben, Fernando Aguirre Palacios, Mahendra Bijarnia, Annik K. Laflamme and Fabio Baschiera

    Version of Record online : 4 OCT 2010, DOI: 10.1111/j.1751-7176.2010.00378.x

  13. You have free access to this content
    Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54-Week, Open-Label Study

    The Journal of Clinical Hypertension

    Volume 14, Issue 12, December 2012, Pages: 821–827, Alexander V. Murray, Wolfgang Koenig, Juan Garcia-Puig, Samir Patel, Alkaz Uddin PhD and Jack Zhang

    Version of Record online : 28 AUG 2012, DOI: 10.1111/j.1751-7176.2012.00706.x

  14. Pharmacokinetics and Pharmacodynamics of Aliskiren/Hydrochlorothiazide Single-Pill Combination Tablets and Free Combination of Aliskiren and Hydrochlorothiazide

    The Journal of Clinical Pharmacology

    Volume 52, Issue 5, May 2012, Pages: 645–655, Dr Jing-He Yan, Dr Venkateswar Jarugula, Dr Ron Sabo, Dr Cheraz Cherif Papst, Dr Jack Zhang and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011405499

  15. Influence of Body Weight and Gender on the Pharmacokinetics, Pharmacodynamics, and Antihypertensive Efficacy of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 50, Issue 12, December 2010, Pages: 1358–1366, Dr Venkateswar Jarugula, Dr Ching-Ming Yeh, Dr Dan Howard, Dr Christopher Bush, Dr Deborah L. Keefe and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009359525

  16. Aliskiren-based stepped-care treatment algorithm provides effective blood pressure control

    International Journal of Clinical Practice

    Volume 65, Issue 5, May 2011, Pages: 613–623, D. Richter, C. Mickel, S. Acharya, P. Brunel and C. Militaru

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1742-1241.2011.02673.x

  17. Effects of Aliskiren, a Direct Renin Inhibitor, on Cardiac Repolarization and Conduction in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 48, Issue 7, July 2008, Pages: 799–811, Dr Surya Ayalasomayajula, Dr Ching-Ming Yeh, Dr Sujata Vaidyanathan, Mr Brian Flannery, Dr Hans Armin Dieterich, Dr Dan Howard, Dr Martin P. Bedigian and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008319330

  18. Aliskiren reduces portal pressure in portal hypertensive rats

    European Journal of Clinical Investigation

    Volume 42, Issue 5, May 2012, Pages: 526–533, Ching-Chih Chang, Wen-Shin Lee, Hui-Chun Huang, Fa-Yauh Lee, Sun-Sang Wang, Han-Chieh Lin, Jing-Yi Nong and Shou-Dong Lee

    Version of Record online : 24 OCT 2011, DOI: 10.1111/j.1365-2362.2011.02611.x

  19. Efficacy, Safety, and Tolerability of Aliskiren Monotherapy Administered With a Light Meal in Elderly Hypertensive Patients: A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Evaluation Study

    The Journal of Clinical Pharmacology

    Volume 52, Issue 12, December 2012, Pages: 1901–1911, Dr Giuseppe Villa, Ms Stephanie Le Breton, Mr Ghionul Ibram and Mr Deborah L. Keefe

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011426432

  20. Itraconazole, a P-Glycoprotein and CYP3A4 Inhibitor, Markedly Raises the Plasma Concentrations and Enhances the Renin-Inhibiting Effect of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 51, Issue 3, March 2011, Pages: 359–367, Tuija Tapaninen, Janne T. Backman, Kaisa J. Kurkinen, Pertti J. Neuvonen and Mikko Niemi

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010365885